Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107


Physical and functional interaction between HCV core protein and the different p73 isoforms.

Alisi A, Giambartolomei S, Cupelli F, Merlo P, Fontemaggi G, Spaziani A, Balsano C.

Oncogene. 2003 May 1;22(17):2573-80.


Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.

Park JS, Kim EJ, Lee JY, Sin HS, Namkoong SE, Um SJ.

Int J Cancer. 2001 Mar 15;91(6):822-7.


Two new p73 splice variants, gamma and delta, with different transcriptional activity.

De Laurenzi V, Costanzo A, Barcaroli D, Terrinoni A, Falco M, Annicchiarico-Petruzzelli M, Levrero M, Melino G.

J Exp Med. 1998 Nov 2;188(9):1763-8.


Activation of p53 tumor suppressor by hepatitis C virus core protein.

Lu W, Lo SY, Chen M, Wu Kj, Fung YK, Ou JH.

Virology. 1999 Nov 10;264(1):134-41.


Regulation of the p53 homolog p73 by adenoviral oncogene E1A.

Das S, El-Deiry WS, Somasundaram K.

J Biol Chem. 2003 May 16;278(20):18313-20. Epub 2003 Mar 13.


Promoter specificity and stability control of the p53-related protein p73.

Lee CW, La Thangue NB.

Oncogene. 1999 Jul 22;18(29):4171-81.


DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes.

Costanzo A, Merlo P, Pediconi N, Fulco M, Sartorelli V, Cole PA, Fontemaggi G, Fanciulli M, Schiltz L, Blandino G, Balsano C, Levrero M.

Mol Cell. 2002 Jan;9(1):175-86.


Differential regulation of transcription and induction of programmed cell death by human p53-family members p63 and p73.

Dietz S, Rother K, Bamberger C, Schmale H, Mössner J, Engeland K.

FEBS Lett. 2002 Aug 14;525(1-3):93-9.


Inactivation of retinoblastoma (RB) tumor suppressor by oncogenic isoforms of the p53 family member p73.

Stiewe T, Stanelle J, Theseling CC, Pollmeier B, Beitzinger M, Pützer BM.

J Biol Chem. 2003 Apr 18;278(16):14230-6. Epub 2003 Feb 12.


Physical and functional interaction between p53 mutants and different isoforms of p73.

Strano S, Munarriz E, Rossi M, Cristofanelli B, Shaul Y, Castagnoli L, Levine AJ, Sacchi A, Cesareni G, Oren M, Blandino G.

J Biol Chem. 2000 Sep 22;275(38):29503-12.


Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis.

Stiewe T, Theseling CC, Pützer BM.

J Biol Chem. 2002 Apr 19;277(16):14177-85. Epub 2002 Feb 13.


Physical interaction of p73 with c-Myc and MM1, a c-Myc-binding protein, and modulation of the p73 function.

Watanabe K, Ozaki T, Nakagawa T, Miyazaki K, Takahashi M, Hosoda M, Hayashi S, Todo S, Nakagawara A.

J Biol Chem. 2002 Apr 26;277(17):15113-23. Epub 2002 Feb 13.


Acquired expression of transcriptionally active p73 in hepatocellular carcinoma cells.

Sayan AE, Sayan BS, Findikli N, Ozturk M.

Oncogene. 2001 Aug 23;20(37):5111-7.


Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line.

Goldschneider D, Blanc E, Raguénez G, Barrois M, Legrand A, Le Roux G, Haddada H, Bénard J, Douc-Rasy S.

J Cell Sci. 2004 Jan 15;117(Pt 2):293-301.


Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity.

Ray RB, Steele R, Meyer K, Ray R.

Gene. 1998 Feb 27;208(2):331-6.


Distinct regulation of p53 and p73 activity by adenovirus E1A, E1B, and E4orf6 proteins.

Steegenga WT, Shvarts A, Riteco N, Bos JL, Jochemsen AG.

Mol Cell Biol. 1999 May;19(5):3885-94.


p73 Interacts with human immunodeficiency virus type 1 Tat in astrocytic cells and prevents its acetylation on lysine 28.

Amini S, Mameli G, Del Valle L, Skowronska A, Reiss K, Gelman BB, White MK, Khalili K, Sawaya BE.

Mol Cell Biol. 2005 Sep;25(18):8126-38.

Supplemental Content

Support Center